{"id":"fgf-2","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reaction"}]},"_chembl":{"chemblId":"CHEMBL1163146","moleculeType":"Protein","molecularWeight":"686.74"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"FGF-2 works by binding to its receptor, FGFR1, to stimulate the growth of new blood vessels and promote the healing of damaged tissues. This process is crucial for wound repair and tissue regeneration. Additionally, FGF-2 has been shown to have anti-inflammatory properties, which may contribute to its therapeutic effects.","oneSentence":"FGF-2 is a fibroblast growth factor that promotes angiogenesis and tissue repair.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:00:12.332Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiac repair and regeneration"}]},"trialDetails":[{"nctId":"NCT07363135","phase":"NA","title":"Evaluation of Albumin Platelet-Rich Fibrin Following SRP in Patients With Periodontitis","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-11-20","conditions":"Periodontitis, Periodontitis (Stage 3)","enrollment":23},{"nctId":"NCT02307916","phase":"PHASE2","title":"Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations","status":"COMPLETED","sponsor":"D. Bradley Welling, MD, PhD","startDate":"2016-10","conditions":"Tympanic Membrane Perforation","enrollment":57},{"nctId":"NCT06448039","phase":"PHASE1, PHASE2","title":"In-office Repair of Chronic Tympanic Membrane Perforations","status":"SUSPENDED","sponsor":"D. Bradley Welling, MD, PhD","startDate":"2024-06-15","conditions":"Chronic Tympanic Membrane Perforation","enrollment":20},{"nctId":"NCT04960384","phase":"PHASE2","title":"Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2022-05-27","conditions":"Tympanic Membrane Perforation","enrollment":52},{"nctId":"NCT02743858","phase":"","title":"Lymphedema Surveillance Study","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2016-04","conditions":"Breast Cancer, Lymphedema","enrollment":1250},{"nctId":"NCT06516939","phase":"NA","title":"The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin","status":"RECRUITING","sponsor":"Shanghai Dermatology Hospital","startDate":"2024-06-10","conditions":"Sensitive Skin","enrollment":28},{"nctId":"NCT04782115","phase":"PHASE2","title":"Evaluation of RC28-E Injection in Diabetic Macular Edema","status":"COMPLETED","sponsor":"RemeGen Co., Ltd.","startDate":"2021-03-17","conditions":"Diabetic Macular Edema","enrollment":156},{"nctId":"NCT02276937","phase":"PHASE2","title":"Randomized Phase IIb Trial of DVC1-0101","status":"UNKNOWN","sponsor":"Kyushu University","startDate":"2014-10","conditions":"Intermittent Claudication, Peripheral Arterial Disease","enrollment":30},{"nctId":"NCT00049530","phase":"PHASE2","title":"PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2004-01-13","conditions":"Melanoma (Skin)","enrollment":32},{"nctId":"NCT04233892","phase":"PHASE1, PHASE2","title":"Clinical Study of in Situ Regeneration of Endometrium","status":"UNKNOWN","sponsor":"Yali Hu","startDate":"2020-04-29","conditions":"Infertility, Female, of Uterine Origin, Endometrial Fibrosis","enrollment":345},{"nctId":"NCT04270669","phase":"PHASE1, PHASE2","title":"Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration","status":"COMPLETED","sponsor":"RemeGen Co., Ltd.","startDate":"2020-04-15","conditions":"Wet Age-Related Macular Degeneration","enrollment":37},{"nctId":"NCT03777254","phase":"PHASE1","title":"Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"RemeGen Co., Ltd.","startDate":"2019-01-07","conditions":"Neovascular Age-related Macular Degeneration","enrollment":12},{"nctId":"NCT01728844","phase":"NA","title":"GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery","status":"COMPLETED","sponsor":"Sunstar Americas","startDate":"2012-10","conditions":"Alveolar Bone Loss, Periodontal Diseases","enrollment":88},{"nctId":"NCT04234321","phase":"NA","title":"Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-08-01","conditions":"Fibroblast Growth Factors, Wound Healing","enrollment":300},{"nctId":"NCT04375618","phase":"PHASE1","title":"RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects","status":"UNKNOWN","sponsor":"SVS Institute of Dental Sciences","startDate":"2019-10-01","conditions":"Periodontitis","enrollment":30},{"nctId":"NCT04361630","phase":"EARLY_PHASE1","title":"Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects","status":"COMPLETED","sponsor":"SVS Institute of Dental Sciences","startDate":"2019-05-01","conditions":"Periodontitis","enrollment":30},{"nctId":"NCT01663298","phase":"","title":"Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-08","conditions":"Smoking, Diabetes","enrollment":44},{"nctId":"NCT03778008","phase":"PHASE2","title":"Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2018-12-21","conditions":"Stomatitis","enrollment":90},{"nctId":"NCT02387749","phase":"NA","title":"Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-05","conditions":"Diabetic Peripheral Neuropathy","enrollment":10},{"nctId":"NCT03279549","phase":"NA","title":"Research on the Key Technology of Burn Wound Treatment","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2018-07-01","conditions":"Burn","enrollment":200},{"nctId":"NCT00427973","phase":"PHASE2","title":"AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-05","conditions":"Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer","enrollment":17},{"nctId":"NCT02844959","phase":"","title":"Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2016-07","conditions":"Atrial Fibrillation","enrollment":120},{"nctId":"NCT00981006","phase":"PHASE1","title":"AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA)","status":"COMPLETED","sponsor":"Naofumi Takehara","startDate":"2010-04","conditions":"Congestive Heart Failure, Ischemic Cardiomyopathy, Ventricular Dysfunction","enrollment":6},{"nctId":"NCT02337166","phase":"PHASE1, PHASE2","title":"Regeneration of Human Intrabony Defects With rhFGF-2/HA","status":"COMPLETED","sponsor":"Universidade Federal Fluminense","startDate":"2002-12","conditions":"Periodontitis","enrollment":30},{"nctId":"NCT00252525","phase":"","title":"Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2007-06","conditions":"Type 2 Diabetes Mellitus","enrollment":400},{"nctId":"NCT01015404","phase":"PHASE3","title":"A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)","status":"COMPLETED","sponsor":"Kaken Pharmaceutical","startDate":"2009-11","conditions":"Periodontitis","enrollment":25},{"nctId":"NCT00734708","phase":"PHASE3","title":"Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)","status":"COMPLETED","sponsor":"Kaken Pharmaceutical","startDate":"2008-08","conditions":"Periodontitis, Alveolar Bone Loss, Periodontal Attachment Loss","enrollment":328},{"nctId":"NCT00216814","phase":"","title":"Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2003-10","conditions":"Bladder Cancer","enrollment":220},{"nctId":"NCT00514657","phase":"PHASE2","title":"Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2","status":"COMPLETED","sponsor":"Kaken Pharmaceutical","startDate":"2001-12","conditions":"Periodontitis","enrollment":91}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FGF2, Human Fibroblast Growth Factor 2"],"phase":"phase_2","status":"active","brandName":"FGF-2","genericName":"FGF-2","companyName":"NYU Langone Health","companyId":"nyu-langone-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FGF-2 is a fibroblast growth factor that promotes angiogenesis and tissue repair. Used for Cardiac repair and regeneration.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}